Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

STU:4E2 (USA)  
€ 2.76 (+1.47%) May 24
At Loss
P/B:
1.30
Market Cap:
€ 85.12M ($ 92.39M)
Enterprise V:
€ 7.79M ($ 8.45M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

My Checklist

Inactive
Item Name
Rating
Action

Fair Value Votes

Date Voted
Fair Value
Price on Date Voted
% Change Since Voted
% Change Relative to SP500
10/Page
Total 0

My Votes

My Vote : €